168 related articles for article (PubMed ID: 22948024)
1. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.
Bellido F; Guinó E; Jagmohan-Changur S; Seguí N; Pineda M; Navarro M; Lázaro C; Blanco I; Vasen HF; Moreno V; Capellá G; Wijnen JT; Valle L
Eur J Hum Genet; 2013 May; 21(5):511-6. PubMed ID: 22948024
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Wiik MU; Evans TJ; Belhadj S; Bolton KA; Dymerska D; Jagmohan-Changur S; Capellá G; Kurzawski G; Wijnen JT; Valle L; Vasen HFA; Lubinski J; Scott RJ; Talseth-Palmer BA
Sci Rep; 2021 May; 11(1):11401. PubMed ID: 34059744
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
5. Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.
Seguí N; Guinó E; Pineda M; Navarro M; Bellido F; Lázaro C; Blanco I; Moreno V; Capellá G; Valle L
PLoS One; 2014; 9(2):e86063. PubMed ID: 24498269
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
[TBL] [Abstract][Full Text] [Related]
7. Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.
Jóri B; Kamps R; Xanthoulea S; Delvoux B; Blok MJ; Van de Vijver KK; de Koning B; Oei FT; Tops CM; Speel EJ; Kruitwagen RF; Gomez-Garcia EB; Romano A
Oncotarget; 2015 Dec; 6(38):41108-22. PubMed ID: 26517685
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
[TBL] [Abstract][Full Text] [Related]
9. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
11. From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.
Lepore Signorile M; Disciglio V; Di Carlo G; Pisani A; Simone C; Ingravallo G
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201893
[TBL] [Abstract][Full Text] [Related]
12. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.
da Silva FC; de Oliveira LP; Santos EM; Nakagawa WT; Aguiar Junior S; Valentin MD; Rossi BM; de Oliveira Ferreira F
Fam Cancer; 2010 Dec; 9(4):563-70. PubMed ID: 20697958
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
14. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
15. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
[TBL] [Abstract][Full Text] [Related]
17. Lynch or not Lynch? Is that always a question?
Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.
Win AK; Clendenning M; Crawford W; Rosty C; Preston SG; Southey MC; Parry S; Giles GG; Macrae FA; Winship IM; Baron JA; Hopper JL; Jenkins MA; Buchanan DD
Genes Cancer; 2015 Nov; 6(11-12):445-51. PubMed ID: 26807197
[TBL] [Abstract][Full Text] [Related]
20. Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
Villacis RA; Miranda PM; Gomy I; Santos EM; Carraro DM; Achatz MI; Rossi BM; Rogatto SR
Int J Cancer; 2016 Apr; 138(8):1928-35. PubMed ID: 26620301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
